Rethinking procurement biopsy in donors with normal renal function: A barrier to kidney utilization without survival benefit

Figure 1 Decision curve analysis for procurement biopsy in deceased donors with preserved renal function, comparing models with clinical variables alone, clinical variables plus biopsy status, and clinical variables plus biopsy pathology. Overlapping curves indicate no incremental net benefit. A: Decision curve analysis (DCA) for 3-year outcomes in the whole cohort; B: DCA for 5-year outcomes in the whole cohort; C: DCA for 3-year outcomes in the biopsied-only cohort; D: DCA analysis for 5-year outcomes in the biopsied-only cohort. DCA: Decision curve analysis.